David E. Kingston, PA-C

David Kingston practices at Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska.

David Kingston's NPI, 1568867638, was assigned on October 30, 2014. David Kingston holds Alaska license 105361.

David Kingston's primary practice is Allergy Asthma and Immunology Center of Alaska, at 3841 Piper St, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-6228.

David Kingston's primary practice is Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska. David Kingston is also affiliated with Providence Alaska Medical Center. The medical group on file is Allergy, Asthma and Immunology Center of Alaska. Dmand AI also links David Kingston to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Kingston practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is David Kingston's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. David Kingston is licensed in Alaska.

CMS data shows 617 Medicare services from David Kingston across 3 procedure codes in 2024, for 29 Medicare patients. Medicare paid $4,527 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw David Kingston in 2024. 59% of them have high blood pressure, and 55% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Kingston's median patient age at 57, with 69% women.

In 2024, David Kingston wrote 978 Medicare Part D claims for 138 patients. 53% of them were for generic drugs. CMS names the drug for 847 of them, across 25 drugs with 11 or more claims each, at $493,442 in total drug cost.

David Kingston accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 239 general payments to David Kingston from 25 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,708.